Insider Trading & Ownership - ARCH Venture Fund VIII Overage L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARCH Venture Fund VIII Overage L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-19
Purchase
2023-09-20
06:15 am
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
1,500,000$17$25,500,0003,624,143
(Indirect)
View
2022-09-13
Purchase
2022-09-15
6:53 pm
Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
5,000,000$1.5$7,500,00013,854,098
(Indirect
Direct)
View
2020-10-16
Purchase
2020-10-20
8:07 pm
Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
235,000$15$3,525,0002,503,903
(Indirect)
View
2020-09-18
Purchase
2020-09-22
11:07 am
Metacrine Inc.MTCRARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
230,000$13$2,990,000158,734
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-08
Other
2023-12-12
7:52 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
1,879,654$032,424,564
(Indirect)
View
2023-09-19
Conversion
2023-09-20
06:15 am
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
17,424,704$03,624,143
(Indirect)
View

Ownership
2023-09-14
9:22 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
0$028,045,420
(Indirect)
View
2020-11-20
Other
2020-11-24
8:59 pm
N/A
N/A
Quanterix CorpQTRXARCH VENTURE FUND VI LP
ARCH Venture Fund VIII Overage L.P.
ARCH VENTURE PARTNERS VI LP
ARCH VENTURE PARTNERS VI LLC
ARCH Venture Partners VIII LLC
BYBEE CLINTON
NELSEN ROBERT
10% Owner
833,211$02,049,870
(Indirect)
View
2020-10-16
Conversion
2020-10-20
8:07 pm
N/A
N/A
Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
30,658,565$02,503,903
(Indirect)
View

Ownership
2020-10-13
9:23 pm
N/A
N/A
Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
0$03,620,109
(Indirect)
View
2020-09-18
Conversion
2020-09-22
11:07 am
N/A
N/A
Metacrine Inc.MTCRARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
2,710,503$0158,734
(Indirect)
View

Ownership
2020-09-15
5:07 pm
N/A
N/A
Metacrine Inc.MTCRARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
0$02,710,503
(Indirect)
View